In other words, although many patients with anxiety disorders have orally reported very intense physiological symptoms in surveys and questionaires, they are hyporeactive when real measures of such symptoms are taken through physiological tests.
This research work has been carried out by Professor Mª Isabel Viedma del Jesus and supervised by dirigida Professors Jaime Vila Castellar and Mª Carmen Fernández- Santaella, of the department of Personality, Evaluation and Physiological Treatment. It was carried out with 83 patients who had been diagnosed any of the following anxiety disorders: panic disorder with and without agoraphobia, social anxiety, generalized anxiety and specific phobias. They all were looked after in the of “Evaluation and Treatment of Anxiety Disorders” of the Clinical Psychology Unit of the Faculty of Psychology.Less serious patients
The researcher emphasizes that, in the light of the results of her research work, it has been proved that, in the clinical evaluation of pathological anxiety should not only undergo cognitive-behavioural tests (traditionally consisting of surveys and questionnaires), but also psycho-physiological tests. “Our research work –Mª Isabel Viedma says- has important clinical implications with regard to the diagnose and prognosis of therapeutic success, as well as in the design of more effective intervention strategies in the field of anxiety disorders”.
Part of the conclusions of this research work have been recently presented in national and international conferences such as those organized by the “Spanish Society of Psychophysiology” (SEPF) and the “Society for Psychophysiological Research” (SPR), among others.Reference:
Carlos Centeno Cuadros | alfa
Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University
Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
22.08.2017 | Health and Medicine
22.08.2017 | Materials Sciences
22.08.2017 | Life Sciences